Seattle Genetics

URI: https://gptkb.org/entity/Seattle_Genetics
GPTKB entity
Statements (22)
Predicate Object
gptkbp:instanceOf gptkb:biotechnology
gptkbp:acquiredBy gptkb:Pfizer
gptkbp:acquisitionYear 2023
gptkbp:CEO gptkb:Clay_Siegall
gptkbp:countryOfOperation gptkb:United_States
gptkbp:developedBy antibody-drug conjugates
gptkbp:focusesOn oncology
gptkbp:foundedBy gptkb:Clay_Siegall
gptkbp:foundedYear 1998
gptkbp:headquartersLocation gptkb:Bothell,_Washington,_United_States
https://www.w3.org/2000/01/rdf-schema#label Seattle Genetics
gptkbp:industry gptkb:biotechnology
gptkbp:notableProduct gptkb:Adcetris
gptkbp:numberOfEmployees ~1500
gptkbp:parentCompany gptkb:Pfizer
gptkbp:publiclyTraded true
gptkbp:renamed gptkb:Seagen_Inc.
gptkbp:stockSymbol gptkb:SGEN
gptkbp:tradedOn gptkb:NASDAQ:_SGEN
gptkbp:website https://www.seagen.com/
gptkbp:bfsParent gptkb:Seagen
gptkbp:bfsLayer 5